RS Investment Management Co. LLC decreased its position in shares of Steris Corp. (NYSE:STE) by 69.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 358,849 shares of the company’s stock after selling 824,018 shares during the period. RS Investment Management Co. LLC’s holdings in Steris Corp. were worth $24,671,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. State Street Corp raised its position in Steris Corp. by 0.3% in the first quarter. State Street Corp now owns 2,687,145 shares of the company’s stock worth $190,922,000 after buying an additional 8,408 shares in the last quarter. BlackRock Institutional Trust Company N.A. raised its position in Steris Corp. by 2.3% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 2,426,099 shares of the company’s stock worth $172,374,000 after buying an additional 54,810 shares in the last quarter. Fisher Asset Management LLC raised its position in Steris Corp. by 0.5% in the second quarter. Fisher Asset Management LLC now owns 1,622,504 shares of the company’s stock worth $112,099,000 after buying an additional 8,584 shares in the last quarter. Wellington Management Group LLP raised its position in Steris Corp. by 1.0% in the first quarter. Wellington Management Group LLP now owns 1,390,731 shares of the company’s stock worth $98,810,000 after buying an additional 13,927 shares in the last quarter. Finally, Norges Bank bought a new position in Steris Corp. during the fourth quarter worth about $85,701,000. Institutional investors and hedge funds own 91.58% of the company’s stock.
Shares of Steris Corp. (NYSE:STE) traded down 1.06% on Friday, reaching $73.12. The company’s stock had a trading volume of 338,162 shares. The stock has a 50-day moving average of $71.21 and a 200 day moving average of $70.04. The stock has a market capitalization of $6.30 billion, a price-to-earnings ratio of 42.00 and a beta of 1.16. Steris Corp. has a 52 week low of $61.38 and a 52 week high of $78.77.
Steris Corp. (NYSE:STE) last posted its quarterly earnings results on Tuesday, August 9th. The company reported $0.79 EPS for the quarter, beating the consensus estimate of $0.77 by $0.02. The firm earned $638.40 million during the quarter, compared to analysts’ expectations of $639.04 million. Steris Corp. had a return on equity of 10.72% and a net margin of 5.52%. The company’s revenue for the quarter was up 45.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.62 EPS. On average, analysts expect that Steris Corp. will post $3.90 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 27th. Shareholders of record on Tuesday, August 30th will be issued a $0.28 dividend. This is a boost from Steris Corp.’s previous quarterly dividend of $0.25. The ex-dividend date of this dividend is Friday, August 26th. This represents a $1.12 annualized dividend and a yield of 1.53%. Steris Corp.’s dividend payout ratio is 68.71%.
STE has been the subject of a number of analyst reports. Zacks Investment Research lowered Steris Corp. from a “hold” rating to a “sell” rating in a research report on Wednesday, August 3rd. Northcoast Research upgraded Steris Corp. from a “neutral” rating to a “buy” rating in a research report on Friday, June 3rd.
In other Steris Corp. news, insider Adrian Vincent Coward sold 15,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 31st. The stock was sold at an average price of $69.00, for a total value of $1,035,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Richard Martin Steeves sold 204,778 shares of the company’s stock in a transaction that occurred on Wednesday, September 7th. The shares were sold at an average price of $71.19, for a total value of $14,578,145.82. Following the completion of the transaction, the director now directly owns 165,434 shares of the company’s stock, valued at approximately $11,777,246.46. The disclosure for this sale can be found here. 2.52% of the stock is owned by company insiders.
Steris Corp. Company Profile
STERIS Corporation (STERIS) is a provider of infection prevention and other procedural products and services. The Company is focused on healthcare, pharmaceutical and research. The Company operates through three business segments: Healthcare, Life Sciences and STERIS Isomedix Services. The Healthcare segment provides surgical, sterile processing, infection prevention and gastrointestinal solutions.
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris Corp. (NYSE:STE).
Receive News & Ratings for Steris Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Corp. and related companies with MarketBeat.com's FREE daily email newsletter.